AssayName: single sample liquid chromatography-tandem mass spectrometry (LC-MS/MS) with data dependent acquisition (DDA)  
AssayName: single sample LC-MS/MS with data independent acquisition (DIA)  
AssayName: peptide fractionation with label-free quantification (LF)  
AssayName: isobaric labeling followed by peptide fractionation (TMT 6-plex)  
AnatomicSiteTumor: lung squamous cell carcinomas  
SupplementaryFile: PXD004682  
SupplementaryFile: PXD004683  
SupplementaryFile: PXD004684  
SupplementaryFile: PXD005733  
Instrument: BioPulverizer (Biospec)  
Compound: 20 mM HEPES  
Compound: 9 M urea  
Compound: 1 mM sodium orthovanadate  
Compound: 2.5 mM sodium pyrophosphate  
Compound: 1 mM β-glycerophosphate  
ReductionReagent: 4.5 mM DTT  
Temperature: 60 °C  
Time: 20 minutes  
AlkylationReagent: 11 mM iodoacetamide  
Temperature: room temperature  
Time: 15 minutes  
ConcentrationOfCompound: 2 M urea  
CleavageAgent: trypsin digestion  
Temperature: 37 °C  
Time: overnight  
FactorValue: enzyme/substrate ratio of 1/50  
Compound: 20% TFA  
ConcentrationOfCompound: final TFA concentration of 1%  
FractionationMethod: basic pH reversed phase HPLC  
ConcentrationOfCompound: 600 µg  
Label: TMT  
ConcentrationOfCompound: 100 µg  
ConcentrationOfCompound: 500 ng  
Instrument: Dionex Ultimate3000 UPLC  
FlowRateChromatogram: 0.2 ml/min  
Instrument: QExactive Plus  
IonizationType: electrospray  
FlowRateChromatogram: 300 nl/min  
CollisionEnergy: normalized collision energy set to 28  
SpikedCompound: PRTC, Pierce #88320  
ConcentrationOfCompound: 10 fmol of each peptide per injection  
Time: 2 days each  
Time: 24 days  
CollisionEnergy: normalized collision energy value was set to 30  
SpikedCompound: PRTC  
ConcentrationOfCompound: 25 femtomoles  
Time: 6 days  
SpikedCompound: PRTC peptide mix